INFECTIOUS DISEASES / CLINICAL RESEARCH
COVID-19 in Poland: potential associations with epidemiology, population and healthcare quality
More details
Hide details
1
Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland
2
Department of Internal Medicine, Tytus Chałubiński’s Hospital, Zakopane, Poland
3
Department of Surgical Medicine, with the Laboratory of Medical Genetics, Collegium Medicum, Jan Kochanowski University, Kielce, Poland
Submission date: 2020-06-04
Final revision date: 2020-07-15
Acceptance date: 2020-07-23
Online publication date: 2020-08-20
Publication date: 2026-05-08
Corresponding author
Katarzyna Orlewska
Faculty of Health Sciences
Medical University of Warsaw
61 Żwirki i Wigury St
02-091 Warsaw, Poland
Phone: +48 600 468 365
Arch Med Sci 2026;22(2):898-903
KEYWORDS
TOPICS
ABSTRACT
Introduction:
An attempt to assess basic epidemiological data was made 2 months after confirming the first case of SARS-CoV-2 in Poland (March 4th, 2020). The aim of the study was to examine which indicators related to epidemiology, population characteristics and health care quality affect COVID-19 incidence, mortality and case fatality in Poland.
Material and methods:
The study was based on national data as of May 4th, 2020. For each voivodeship incidence rates, mortality rates, case fatality rates and daily cumulative index (DCI) were calculated. The correlations were examined using Pearson’s and Spearman’s rank correlation coefficient, with a significance level of p < 0.05 (2-tailed tests).
Results:
The overall COVID-19 incidence rate was 3.65 per 10,000 population, mortality rate 0.18 per 10,000 population and case fatality rate 5%. All three disease indicators were positively correlated with DCI and negatively correlated with the number of hospital beds in infectious diseases wards per 10,000 population. Both incidence and mortality rates were positively correlated with population density and number of cases per COVID-19 designated hospital.
Conclusions:
The positive correlation between DCI and both mortality and case fatality suggests that DCI could be considered as an indirect indicator of healthcare burden, compared to incidence rate alone. Our analysis confirms the role of social distancing in reducing viral transmission. The results could be useful for policymakers to plan ahead in order to relieve the risk of healthcare system overload during the current and future epidemics.
REFERENCES (26)
2.
World Health Organization (WHO); Coronavirus disease 2019 (COVID-19) Situation Report – 50; 5.
3.
Nowak B, Szymański P, Pańkowski I, et al. Clinical characteristics and short-term outcomes of patients with coronavirus disease 2019: a retrospective single-center experience of a designated hospital in Poland. Pol Arch Intern Med 2020; 130: 407-11.
8.
Kozierkiewicz A, Natkaniec M, Megas B, Gilewski D, Ignatowicz M, Waśko B. PWC. Health Care Fitness Index 2018; 11–13.
10.
Central Statistical Office. Health and Health care in 2016. 82.
12.
Burlacu A, Mavrichi I, Crisan-Dabija R, et al. “Celebrating old age”: an obsolete expression during the COVID-19 pandemic? Medical, social, psychological, and religious consequences of home isolation and loneliness among the elderly. Arch Med Sci 2021; 17: 285-95.
14.
Knapik P, Knapik M, Trejnowska E, et al. Should we admit more patients not requiring invasive ventilation to reduce excess mortality in Polish intensive care units? Data from the Silesian ICU Registry. Arch Med Sci 2019; 15: 1313-20.
15.
Prem K, Liu Y, Russell TW, et al. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study. Lancet Public Heal 2020; 5: 261-70.
16.
Sjödin H, Wilder-Smith A, Osman S, Farooq Z, Rocklöv J. Only strict quarantine measures can curb the coronavirus disease (COVID-19) outbreak in Italy, 2020. Eurosurveillance 2020; 25: pii=2000280.
17.
Petretto DR, Pili R. Ageing and COVID-19: what is the role for elderly people? Geriatr 2020; 5: 25.
18.
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054-62.
19.
Piątek Ł, Wilczek K, Kurzawski J, et al. Gender-related disparities in the treatment and outcomes in patients with non-ST-segment elevation myocardial infarction: results from the Polish Registry of Acute Coronary Syndromes (PL-ACS) in the years 2012–2014. Arch Med Sci 2020; 16: 781-8.
20.
Cismaru A, Cismaru L, Nabavi S, et al. Game of “crowning” season 8: RAS and reproductive hormones in COVID-19 – can we end this viral series? Arch Med Sci 2021; 17: 275-84.
21.
Katsiki N, Banach M, Mikhailidis D. Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic. Arch Med Sci 2020; 16: 485-9.
22.
Bianconi V, Bronzo P, Banach M, Sahebkar A, Mannarino M, Pirro M. Particulate matter pollution and the COVID-19 outbreak: results from Italian regions and provinces. Arch Med Sci 2020; 16: 985-92.
23.
Lai CC, Wang CY, Wang YH, Hsueh SC, Ko WC, Hsueh PR. Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status. Int J Antimicrob Agents 2020; 55: 105946.
24.
Lai CC, Wang CY, Wang YH, Hsueh PR. Global coronavirus disease 2019: What has daily cumulative index taught us? Int J Antimicrob Agents 2020; 55: 106001.
25.
Ji Y, Ma Z, Peppelenbosch MP, Pan Q. Potential association between COVID-19 mortality and healthcare resource availability. Lancet Glob Heal 2020; 8: e480.
26.
Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet 2020; 395: 1225-8.